BFA
RARX

BlackRock Fund Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

BlackRock Fund Advisors’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.62M Buy
+238,058
New +$3.24M ﹤0.01% 3039

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BlackRock Fund Advisors's RARX Position: Q4 2016 in Review

BlackRock Fund Advisors opened a new position in Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2016: 238,058 shares worth $3.62M. The stake represents ﹤0.01% of the portfolio and ranks #3039 among its holdings.

59 funds tracked by Wall St. Rank hold RARX as of Q4 2016.

  • BlackRock Fund Advisors held 238,058 shares of Ra Pharmaceuticals, Inc. Common Stock worth $3.62M as of Q4 2016.
  • Ra Pharmaceuticals, Inc. Common Stock was a new BlackRock Fund Advisors position in Q4 2016.
  • Ra Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3039 holding.
  • 59 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.